Tinea Corporis

Authors

  • Wina Adelia Pasaribu Universitas Malikussaleh
  • Malahayati Malahayati RSUD dr. Fauziah Bireuen

DOI:

https://doi.org/10.62383/ikg.v2i2.1546

Keywords:

Dermatophyte, Itraconazole, Tinea corporis

Abstract

Approximately 35.4% of the Asian population suffers from Tinea corporis, a superficial dermatophyte fungal infection that attacks hairless skin such as the face, arms, and legs. This dermatophyte causes symptoms in the form of circular lesions with active red and scaly edges and a calmer center. This case involved a 12-year-old girl who came to the Dermatology and Venereology Polyclinic of Fauziah Bireun Hospital with complaints of reddish spots on her body that had lasted for eight months. The lesions were accompanied by itching, especially when sweating or in hot conditions, but improved after bathing. The clinical diagnosis showed Tinea corporis. The therapy given was 2% ketoconazole cream applied twice a day and systemic treatment with 200 mg itraconazole and 10 mg cetirizine. This management aims to overcome fungal infections, reduce symptoms, and prevent recurrence. Patient education regarding personal hygiene and prevention of skin moisture is an important part of therapy.

References

Assandi, P. (2016). Upaya pengobatan dasar kasus tinea korporis.

Desyanti, N. (2019). Skabies dan tinea cruris et corporis..

Fauzia, T. A. S. (2020). Penatalaksanaan pasien tinea korporis pembuat kerupuk dengan pendekatan kedokteran keluarga. Majority, 9(1), 12–18.

Gadithya, I. D. G., Darmada, I. G., & R, L. M. M. (2015). Tinea korporis et kruris. e-Jurnal Medika Udayana, 3(4), 449–462.

Ghinanda, R. S., & Topik, M. M. (2024). Tinea corporis et cruris. Termom Journal, 2(2)..

Kurniadi, R., & Aprilla, N. (2022). Faktor yang berhubungan dengan kejadian tinea corporis (kurap) di Desa Nelayan wilayah kerja Puskesmas Jambu Kabupaten Rokan Hilir. Jurnal Kesehatan Terpadu, 1(1), 79–88.

Leung, A. K. C., Lam, J. M., Leong, K. F., & Hon, K. L. (2020). Tinea corporis: An updated review. Drugs in Context, 9, 1–12. https://doi.org/10.7573/dic.2020-4-2

PERDOSKI. (2017). Panduan praktik klinis. Journal of Organic Chemistry, 74, 3203–3206.

Putri, M. N., Burmana, F., & Nusadewiarti, A. (2017). Penatalaksanaan dan pencegahan tinea korporis pada pasien wanita dan anggota keluarga. Jurnal Agromed Unila, 1(4).

Rizki, A., Prasetia, D., Effendi, R., Pada, P., Usia, W., Dengan, T., et al. (2022). Penatalaksanaan pada wanita usia 34 tahun dengan tinea pedis melalui pendekatan kedokteran keluarga. Medical Profession Journal Lampung, 12(3), 4–6.

Sahoo, A., & Mahajan, R. (2016). Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatology Online Journal, 7(2), 77–86. https://doi.org/10.4103/2229-5178.178099

Sanggarwati, S. Y. D. R., Wahyunitisari, M. R., Astari, L., & Ervianti, E. (2021). Profile of tinea corporis and tinea cruris in dermatovenereology clinic of tertiary hospital: A retrospective study. Berkala Ilmu Kesehatan Kulit dan Kelamin, 33(1), 34–40.

Warouw, M. W., Kairupan, T. S., & Suling, P. L. (2021). Efektivitas anti jamur sistemik terhadap dermatofitosis. Jurnal Biomedik, 13(2), 185–190.

Yee, G., & Al Aboud, A. M. (2023). Tinea corporis. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK499914/

Downloads

Published

2025-05-06

How to Cite

Wina Adelia Pasaribu, & Malahayati Malahayati. (2025). Tinea Corporis. Inovasi Kesehatan Global, 2(2), 140–144. https://doi.org/10.62383/ikg.v2i2.1546